Zenas BioPharma Inc. Company Profile
NASDAQ: ZBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 1:53 PM ET
Zenas BioPharma at a glance
Zenas BioPharma Inc. (NASDAQ: ZBIO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Zenas BioPharma is led by Mr. Leon Oliver Moulder Jr., M.B.A. and employs about 167 people. The company's shares have traded publicly since 2024.
At a market capitalization of $1.71 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001953926, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Zenas BioPharma do?
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Zenas BioPharma Inc.
- Ticker
- NASDAQ: ZBIO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Leon Oliver Moulder Jr., M.B.A.
- Employees
- 167
- Headquarters
- 852 Winter Street, Waltham, MA, United States
- Phone
- 857 271 2954
- Website
- zenasbio.com
- IPO year
- 2024
- Market cap
- $1.71B
- SEC CIK
- 0001953926
Companies similar to Zenas BioPharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANIPANI Pharmaceuticals Inc. | 74.09 | +2.93% | $1.70B | vs ZBIO |
| OCULOcular Therapeutix Inc. | 7.63 | +1.53% | $1.67B | vs ZBIO |
| NUVBNuvation Bio Inc. Class A | 5.04 | +1.72% | $1.77B | vs ZBIO |
| CMPSCOMPASS Pathways Plc American Depository Shares | 11.92 | +3.88% | $1.65B | vs ZBIO |
| BRVEBraveheart Bio Inc. | 19.76 | +3.48% | $1.78B | vs ZBIO |
| SEPNSepterna Inc. | 38.35 | +3.92% | $1.79B | vs ZBIO |
| STOKStoke Therapeutics Inc. | 24.94 | +4.13% | $1.61B | vs ZBIO |
| KRSAKorsana Biosciences Inc. | 35.27 | +5.24% | $1.61B | vs ZBIO |